Natco Pharma has received the establishment inspection report (EIR) for its Kothur facility in Telangana from the US health regulator after successful completion of inspection....
Natco Pharma has launched generic sofosbuvir 400 mg/velpatasvir 100 mg tablets that are used in treatment of chronic hepatitis C, in India. Natco Pharma has...
Natco Pharma, after receiving final approval from the US health regulator in August this year, launched a generic Tamiflu capsules that are used in the...
Natco Pharma has got the US health regulator’s approval for generic version of Budesonide capsules that are used for treatment of active Crohn’s disease for...
Natco Pharma has said that its marketing partner Mylan Inc has got tentative approval from the US health regulator for selling generic Sorafenib tablets that...
A non-exclusive licensing agreement has been signed by Natco Pharma with the Medicines Patent Pool (MPP) and Bristol-Myers Squibb for manufacturing and selling generic version...